Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., . . . Ambs, S. (2013). MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. American Society for Clinical Investigation.
استشهاد بنمط شيكاغوTerunuma, Atsushi, et al. MYC-driven Accumulation of 2-hydroxyglutarate Is Associated With Breast Cancer Prognosis. American Society for Clinical Investigation, 2013.
MLA استشهادTerunuma, Atsushi, et al. MYC-driven Accumulation of 2-hydroxyglutarate Is Associated With Breast Cancer Prognosis. American Society for Clinical Investigation, 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.